SKF India Ltd: Intrinsic Value & Share Price Analysis

Last Updated: February 3, 2026, 2:59 am

All Competitor Stocks of SKF India Ltd

Last Updated: December 29, 2025, 3:04 am

Below is a detailed analysis of the quarterly data for SKF India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 496.00 Cr.. The value appears strong and on an upward trend. It has increased from 462.00 Cr. (Jun 2025) to 496.00 Cr., marking an increase of 34.00 Cr..
• For Expenses, as of Sep 2025, the value is 438.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 389.00 Cr. (Jun 2025) to 438.00 Cr., marking an increase of 49.00 Cr..
• For Operating Profit, as of Sep 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Jun 2025) to 58.00 Cr., marking a decrease of 16.00 Cr..
• For OPM %, as of Sep 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Jun 2025) to 12.00%, marking a decrease of 4.00%.
• For Other Income, as of Sep 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 77.00 Cr. (Jun 2025) to 74.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
• For Depreciation, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Sep 2025, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 135.00 Cr. (Jun 2025) to 116.00 Cr., marking a decrease of 19.00 Cr..
• For Tax %, as of Sep 2025, the value is 9.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Jun 2025) to 9.00%, marking a decrease of 3.00%.
• For Net Profit, as of Sep 2025, the value is 106.00 Cr.. The value appears to be declining and may need further review. It has decreased from 119.00 Cr. (Jun 2025) to 106.00 Cr., marking a decrease of 13.00 Cr..
• For EPS in Rs, as of Sep 2025, the value is 21.39. The value appears to be declining and may need further review. It has decreased from 24.01 (Jun 2025) to 21.39, marking a decrease of 2.62.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 4:37 am

Last Updated: September 5, 2025, 1:31 pm

Last Updated: January 7, 2026, 4:25 pm

Below is a detailed analysis of the balance sheet data for SKF India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 49.00 Cr..
• For Reserves, as of Sep 2025, the value is 2,705.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,549.00 Cr. (Mar 2025) to 2,705.00 Cr., marking an increase of 156.00 Cr..
• For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 7.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 5.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,116.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 959.00 Cr. (Mar 2025) to 1,116.00 Cr., marking an increase of 157.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,873.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,564.00 Cr. (Mar 2025) to 3,873.00 Cr., marking an increase of 309.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 408.00 Cr.. The value appears to be declining and may need further review. It has decreased from 551.00 Cr. (Mar 2025) to 408.00 Cr., marking a decrease of 143.00 Cr..
• For CWIP, as of Sep 2025, the value is 56.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 56.00 Cr..
• For Investments, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
• For Other Assets, as of Sep 2025, the value is 3,400.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,948.00 Cr. (Mar 2025) to 3,400.00 Cr., marking an increase of 452.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,873.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,564.00 Cr. (Mar 2025) to 3,873.00 Cr., marking an increase of 309.00 Cr..

Notably, the Reserves (2,705.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for SKF India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 114.50. This value is within the healthy range. It has increased from 111.60 (Mar 24) to 114.50, marking an increase of 2.90.
• For Diluted EPS (Rs.), as of Mar 25, the value is 114.50. This value is within the healthy range. It has increased from 111.60 (Mar 24) to 114.50, marking an increase of 2.90.
• For Cash EPS (Rs.), as of Mar 25, the value is 131.23. This value is within the healthy range. It has increased from 126.69 (Mar 24) to 131.23, marking an increase of 4.54.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 525.48. It has decreased from 542.63 (Mar 24) to 525.48, marking a decrease of 17.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 525.48. It has decreased from 542.63 (Mar 24) to 525.48, marking a decrease of 17.15.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 995.13. It has increased from 924.38 (Mar 24) to 995.13, marking an increase of 70.75.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 171.28. This value is within the healthy range. It has increased from 164.16 (Mar 24) to 171.28, marking an increase of 7.12.
• For PBIT / Share (Rs.), as of Mar 25, the value is 154.48. This value is within the healthy range. It has increased from 149.07 (Mar 24) to 154.48, marking an increase of 5.41.
• For PBT / Share (Rs.), as of Mar 25, the value is 154.33. This value is within the healthy range. It has increased from 148.82 (Mar 24) to 154.33, marking an increase of 5.51.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 114.43. This value is within the healthy range. It has increased from 111.60 (Mar 24) to 114.43, marking an increase of 2.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 114.46. This value is within the healthy range. It has increased from 111.61 (Mar 24) to 114.46, marking an increase of 2.85.
• For PBDIT Margin (%), as of Mar 25, the value is 17.21. This value is within the healthy range. It has decreased from 17.75 (Mar 24) to 17.21, marking a decrease of 0.54.
• For PBIT Margin (%), as of Mar 25, the value is 15.52. This value is within the healthy range. It has decreased from 16.12 (Mar 24) to 15.52, marking a decrease of 0.60.
• For PBT Margin (%), as of Mar 25, the value is 15.50. This value is within the healthy range. It has decreased from 16.09 (Mar 24) to 15.50, marking a decrease of 0.59.
• For Net Profit Margin (%), as of Mar 25, the value is 11.49. This value exceeds the healthy maximum of 10. It has decreased from 12.07 (Mar 24) to 11.49, marking a decrease of 0.58.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.50. This value is within the healthy range. It has decreased from 12.07 (Mar 24) to 11.50, marking a decrease of 0.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.78. This value is within the healthy range. It has increased from 20.56 (Mar 24) to 21.78, marking an increase of 1.22.
• For Return on Capital Employeed (%), as of Mar 25, the value is 28.78. This value is within the healthy range. It has increased from 27.06 (Mar 24) to 28.78, marking an increase of 1.72.
• For Return On Assets (%), as of Mar 25, the value is 15.87. This value is within the healthy range. It has increased from 15.11 (Mar 24) to 15.87, marking an increase of 0.76.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.36. It has increased from 1.34 (Mar 24) to 1.36, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has decreased from 2.95 (Mar 24) to 2.82, marking a decrease of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 1.86. This value is within the healthy range. It has decreased from 2.22 (Mar 24) to 1.86, marking a decrease of 0.36.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.32. This value is within the healthy range. It has increased from 1.69 (Mar 24) to 6.32, marking an increase of 4.63.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 113.56. This value exceeds the healthy maximum of 50. It has increased from 35.83 (Mar 24) to 113.56, marking an increase of 77.73.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 99.02. This value exceeds the healthy maximum of 50. It has increased from 31.56 (Mar 24) to 99.02, marking an increase of 67.46.
• For Earning Retention Ratio (%), as of Mar 25, the value is -13.56. This value is below the healthy minimum of 40. It has decreased from 64.17 (Mar 24) to -13.56, marking a decrease of 77.73.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 40. It has decreased from 68.44 (Mar 24) to 0.98, marking a decrease of 67.46.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1,209.73. This value is within the healthy range. It has increased from 670.74 (Mar 24) to 1,209.73, marking an increase of 538.99.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 809.20. This value is within the healthy range. It has increased from 457.01 (Mar 24) to 809.20, marking an increase of 352.19.
• For Enterprise Value (Cr.), as of Mar 25, the value is 18,303.46. It has decreased from 19,358.28 (Mar 24) to 18,303.46, marking a decrease of 1,054.82.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 3. It has decreased from 4.24 (Mar 24) to 3.72, marking a decrease of 0.52.
• For EV / EBITDA (X), as of Mar 25, the value is 21.61. This value exceeds the healthy maximum of 15. It has decreased from 23.85 (Mar 24) to 21.61, marking a decrease of 2.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.87. This value exceeds the healthy maximum of 3. It has decreased from 4.50 (Mar 24) to 3.87, marking a decrease of 0.63.
• For Retention Ratios (%), as of Mar 25, the value is -13.56. This value is below the healthy minimum of 30. It has decreased from 64.16 (Mar 24) to -13.56, marking a decrease of 77.72.
• For Price / BV (X), as of Mar 25, the value is 7.32. This value exceeds the healthy maximum of 3. It has decreased from 7.67 (Mar 24) to 7.32, marking a decrease of 0.35.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.87. This value exceeds the healthy maximum of 3. It has decreased from 4.50 (Mar 24) to 3.87, marking a decrease of 0.63.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis